People with MS have persistently high levels of EBV antibodies, a study found, pointing to a way to distinguish MS from ...

Creative Biolabs today announced the upgrade of its next-generation drug discovery pipeline with integrated AI-driven ...

Now, researchers at the University of California, San Francisco (UCSF), have discovered that Src also appears like a flag on the surface of bladder, colorectal, breast, pancreatic, and probably many ...

Amydis has received $2.5 million to continue mapping toxic deposits of TDP-43 in retinal tissue and develop an eye test for ALS.

Researchers identified a blood immune signature linked to amyloid-related imaging abnormalities in patients receiving Alzheimer’s antibody therapy. The findings may help predict treatment side effects ...

When tracked across calves and over time, serum total protein can provide insights into calf health, management consistency ...

A multi-center study led by researchers at Cincinnati Children's sheds new light on why some newborns become severely ill from Escherichia coli infection, but others do not. It turns out that most ...

Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...

A study shows combining immune responses to two viral proteins lowers influenza transmission and replication, without triggering escape variants, improving future vaccine design.

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's generative model for protein ...